Literature DB >> 11158133

Development of monoclonal antibodies which specifically recognize Entamoeba histolytica in preserved stool samples.

Y C Yau1, I Crandall, K C Kain.   

Abstract

We report the generation of monoclonal antibodies against a recombinant 170-kDa subunit of the Gal or GalNAc lectin of Entamoeba histolytica that specifically recognize E. histolytica but not Entamoeba dispar in preserved stool samples. These antibodies do not cross-react with other bowel protozoa, including Entamoeba coli, Giardia lamblia, and Dientamoeba fragilis.

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11158133      PMCID： PMC87802          DOI： 10.1128/JCM.39.2.716-719.2001

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  28 in total

1.  Diagnosis of Entamoeba histolytica and Entamoeba dispar in clinical specimens by PCR-SHELA.

Authors:  A Aguirre; S Molina; C Blotkamp; J Verveij; T Vinuesa; M E Valls; F Guhl; A Polderman; M T Jimenez de Anta; M Corachan; A González-Ruiz; I A Frame; D Warhurst
Journal:  Arch Med Res       Date:  1997       Impact factor: 2.235

2.  Antigenic stability and immunodominance of the Gal/GalNAc adherence lectin of Entamoeba histolytica.

Authors:  W A Petri; J Broman; G Healy; T Quinn; J I Ravdin
Journal:  Am J Med Sci       Date:  1989-03       Impact factor: 2.378

3.  Subunit structure of the galactose and N-acetyl-D-galactosamine-inhibitable adherence lectin of Entamoeba histolytica.

Authors:  W A Petri; M D Chapman; T Snodgrass; B J Mann; J Broman; J I Ravdin
Journal:  J Biol Chem       Date:  1989-02-15       Impact factor: 5.157

4.  The differentiation of invasive and non-invasive Entamoeba histolytica by isoenzyme electrophoresis.

Authors:  P G Sargeaunt; J E Williams; J D Grene
Journal:  Trans R Soc Trop Med Hyg       Date:  1978       Impact factor: 2.184

5.  Antibodies to major histocompatibility antigens produced by hybrid cell lines.

Authors:  G Galfre; S C Howe; C Milstein; G W Butcher; J C Howard
Journal:  Nature       Date:  1977-04-07       Impact factor: 49.962

6.  Immunological differentiation of pathogenic and non-pathogenic isolates of Entamoeba histolytica.

Authors:  W D Strachan; P L Chiodini; W M Spice; A H Moody; J P Ackers
Journal:  Lancet       Date:  1988-03-12       Impact factor: 79.321

Review 7.  Problems in recognition and diagnosis of amebiasis: estimation of the global magnitude of morbidity and mortality.

Authors:  J A Walsh
Journal:  Rev Infect Dis       Date:  1986 Mar-Apr

8.  Primary structure of the 170-kDa surface lectin of pathogenic Entamoeba histolytica.

Authors:  E Tannich; F Ebert; R D Horstmann
Journal:  Proc Natl Acad Sci U S A       Date:  1991-03-01       Impact factor: 11.205

9.  Pathogenic and nonpathogenic strains of Entamoeba histolytica can be differentiated by monoclonal antibodies to the galactose-specific adherence lectin.

Authors:  W A Petri; T F Jackson; V Gathiram; K Kress; L D Saffer; T L Snodgrass; M D Chapman; Z Keren; D Mirelman
Journal:  Infect Immun       Date:  1990-06       Impact factor: 3.441

10.  Isolation of the galactose-binding lectin that mediates the in vitro adherence of Entamoeba histolytica.

Authors:  W A Petri; R D Smith; P H Schlesinger; C F Murphy; J I Ravdin
Journal:  J Clin Invest       Date:  1987-11       Impact factor: 14.808
View more
  2 in total

Review 1.  The role of lipopeptidophosphoglycan in the immune response to Entamoeba histolytica.

Authors:  Isabel Wong-Baeza; Marcela Alcántara-Hernández; Ismael Mancilla-Herrera; Itzmel Ramírez-Saldívar; Lourdes Arriaga-Pizano; Eduardo Ferat-Osorio; Constantino López-Macías; Armando Isibasi
Journal:  J Biomed Biotechnol       Date:  2010-01-21

2.  Differentiating Entamoeba histolytica, Entamoeba dispar and Entamoeba moshkovskii using nested polymerase chain reaction (PCR) in rural communities in Malaysia.

Authors:  Romano Ngui; Lorainne Angal; Siti Aminah Fakhrurrazi; Yvonne Lim Ai Lian; Lau Yee Ling; Jamaiah Ibrahim; Rohela Mahmud
Journal:  Parasit Vectors       Date:  2012-09-04       Impact factor: 3.876
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.